Several chronic cardiovascular diseases characterized by myofibroblast-induced maladaptive remodelling, including hypertension, coronary heart disease, atherosclerosis, heart failure, fibrosis are linked to elevated levels of Angiotensin II (Ang II), and activation of Ang II receptors[22], [24]. This evidence concerns the gene AGT and coronary artery disorder.